Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Cu |
| Molecular Weight | 63.546 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cu]
InChI
InChIKey=RYGMFSIKBFXOCR-UHFFFAOYSA-N
InChI=1S/Cu
| Molecular Formula | Cu |
| Molecular Weight | 63.546 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
COPPER is a heavy metal trace element with the atomic symbol Cu. It is commonly used in contraceptive intrauterine devices (IUD) which birth control effectiveness is enhanced by COPPER continuously released into the uterine cavity. Mechanism(s) by which COPPER enhances contraceptive efficacy include interference with sperm transport and fertilization of an egg, and possibly prevention of implantation.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. | 2004-03-01 |
|
| Copper-inducible transcription: regulation by metal- and oxidative stress-responsive pathways. | 2004-02 |
|
| Actin and microtubule regulation of trans-Golgi network architecture, and copper-dependent protein transport to the cell surface. | 2003-12-12 |
|
| Identification of metal-binding proteins in human hepatoma lines by immobilized metal affinity chromatography and mass spectrometry. | 2003-12 |
|
| Copper chelation delays the onset of prion disease. | 2003-11-21 |
|
| Copper deficiency increases iron absorption in the rat. | 2003-11 |
|
| Prion, amyloid beta-derived Cu(II) ions, or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate. | 2003-10-03 |
|
| Gene expression in the liver of Long-Evans cinnamon rats during the development of hepatitis. | 2003-10 |
|
| Copper modulates the degradation of copper chaperone for Cu,Zn superoxide dismutase by the 26 S proteosome. | 2003-09-12 |
|
| Mechanisms of biosynthesis of mammalian copper/zinc superoxide dismutase. | 2003-08-29 |
|
| Redox labile site in a Zn4 cluster of Cu4,Zn4-metallothionein-3. | 2003-08-19 |
|
| Expression of normal cellular prion protein (PrP(c)) on T lymphocytes and the effect of copper ion: Analysis by wild-type and prion protein gene-deficient mice. | 2003-08-08 |
|
| Changes in protein expression profiles in bivalve molluscs (Chamaelea gallina) exposed to four model environmental pollutants. | 2003-08 |
|
| The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells. | 2003-08 |
|
| Copper induces the expression of cholesterogenic genes in human macrophages. | 2003-07 |
|
| Protective action of CLA against oxidative inactivation of paraoxonase 1, an antioxidant enzyme. | 2003-06 |
|
| Female rats are protected against oxidative stress during copper deficiency. | 2003-06 |
|
| In vitro effect of metal ions on the activity of two amphibian glyceraldehyde-3-phosphate dehydrogenases: potential metal binding sites. | 2003-06 |
|
| Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. | 2003-05-09 |
|
| Thioredoxin peroxidases can foster cytoprotection or cell death in response to different stressors: over- and under-expression of thioredoxin peroxidase in Drosophila cells. | 2003-05-01 |
|
| Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. | 2003-03-15 |
|
| Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. | 2003-03-14 |
|
| Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. | 2003-03-14 |
|
| The PrP-like protein Doppel binds copper. | 2003-03-14 |
|
| Copper-deficient rat embryos are characterized by low superoxide dismutase activity and elevated superoxide anions. | 2003-03 |
|
| Gastrointestinal symptoms and blood indicators of copper load in apparently healthy adults undergoing controlled copper exposure. | 2003-03 |
|
| Copper-binding proteins in human erythrocytes: searching for potential biomarkers of copper over-exposure. | 2003-03 |
|
| Copper reduction by copper binding proteins and its relation to neurodegenerative diseases. | 2003-03 |
|
| Identification of novel mutations and the three most common mutations in the human ATP7B gene of Korean patients with Wilson disease. | 2003-01-25 |
|
| Copper deficiency induces the upregulation of the copper chaperone for Cu/Zn superoxide dismutase in weanling male rats. | 2003-01 |
|
| Mutation analysis of copper transporter genes in patients with ethylmalonic encephalopathy, mitochondriopathies and copper deficiency phenotypes. | 2003 |
|
| The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production. | 2002-12-10 |
|
| Copper-regulated trafficking of the Menkes disease copper ATPase is associated with formation of a phosphorylated catalytic intermediate. | 2002-11-29 |
|
| A conditional mutation affecting localization of the Menkes disease copper ATPase. Suppression by copper supplementation. | 2002-11-15 |
|
| Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. | 2002-11 |
|
| Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). | 2002-10-25 |
|
| Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. | 2002-10-25 |
|
| Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. | 2002-10-10 |
|
| Structure and dynamics of copper-free SOD: The protein before binding copper. | 2002-10 |
|
| Effects of copper on the expression of metal transporters in human intestinal Caco-2 cells. | 2002-09-11 |
|
| Correlation between automated writing movements and striatal dopaminergic innervation in patients with Wilson's disease. | 2002-08 |
|
| Metal- and tissue-dependent relationship between metallothionein mRNA and protein. | 2002-07-15 |
|
| Photosensitized paraquat-induced structural alterations and free radical mediated fragmentation of serum albumin. | 2002-07 |
|
| Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. | 2002-07 |
|
| A distinct Cu(4)-thiolate cluster of human metallothionein-3 is located in the N-terminal domain. | 2002-06 |
|
| Human kidney diamine oxidase: heterologous expression, purification, and characterization. | 2002-06 |
|
| Nuclear proteins that bind to metal response element a (MREa) in the Wilson disease gene promoter are Ku autoantigens and the Ku-80 subunit is necessary for basal transcription of the WD gene. | 2002-04 |
|
| Differential regulation of the two metallothionein genes in common carp. | 2002 |
|
| Copper enhances isoproterenol toxicity in isolated rat cardiomyocytes: effects on oxidative stress. | 2001 |
|
| The determination of copper in biological materials by flame spectrophotometry. | 1962-03 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:07:04 GMT 2025
by
admin
on
Mon Mar 31 18:07:04 GMT 2025
|
| Record UNII |
789U1901C5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000175830
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NDF-RT |
N0000005747
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NCI_THESAURUS |
C896
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
CFR |
21 CFR 102.23
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NDF-RT |
N0000175831
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
DSLD |
45 (Number of products:5510)
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
CFR |
21 CFR 862.1190
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
LIVERTOX |
NBK548090
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
WHO-ATC |
G02BA02
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NDF-RT |
N0000008595
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NCI_THESAURUS |
C637
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NDF-RT |
N0000005747
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
WHO-VATC |
QG02BA02
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NDF-RT |
N0000005747
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
EPA PESTICIDE CODE |
22501
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
NDF-RT |
N0000008924
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
||
|
LOINC |
56126-6
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23978
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
7440-50-8
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
100000091100
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
DTXSID2023985
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
SUB13454MIG
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
789U1901C5
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
231-159-6
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
m3774
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | Merck Index | ||
|
Intrauterine Copper Contraceptive
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
30052
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
CHEMBL55643
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
DB09130
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
1622
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
28694
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
2837
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | RxNorm | ||
|
C391
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
789U1901C5
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY | |||
|
D003300
Created by
admin on Mon Mar 31 18:07:04 GMT 2025 , Edited by admin on Mon Mar 31 18:07:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |